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Abstract
Background
In 2012, the Canadian Society of Cardiology indicated that patients supported with
left ventricular assist device (LVAD) may drive a private vehicle 2 months after
implantation, provided they are deemed clinically stable. Objective evidence
supporting this recommendation is limited. We sought to compare data regarding
driving habits in our patients following LVAD implantation.
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Methods
A standard questionnaire addressing driving patterns before and after LVAD
implantation was sent to all living patients who had received an LVAD between
January 2010 and January 2014. Ninety-four of 124 patients responded (average
age 58 years, 69.2% men, 77.7% bridge to transplant).
Results
Prior to LVAD, all were living at home, 33% were employed, and 93% were driving.
Sixty-nine percent indicated they drove after LVAD implantation; they were
younger (56 vs 62 years, p=0.02) and had providers recommendation (p=0.004).
Four of seven patients who had not driven before started driving (p<0.0001). Most
patients (56%) initiated driving between weeks 2 and 8 after discharge. Ten (16%)
patients experienced alarms while driving (6 related to batteries, 2 suction events,
2 other); all were safely addressed. One patient had syncope and a motor vehicle
accident without fatalities. Ninety four percent believed driving positively impacts
quality of life, and 26% believed having an LVAD significantly affects driving ability.
Conclusions
Most patients returned to driving after LVAD implantation. A minority had LVADassociated alarms that were easily addressed. We suggest inclusion of driving
habits in registries to provide clarity on the safety of driving while being supported
with LVAD.
Keywords: left ventricular assist device, end-stage heart failure, driving,
automobiles, cars

Introduction
Left ventricular assist devices (LVADs) have demonstrated increased quantity and
quality of life for both destination therapy and bridge to transplantation (BTT)
indications. Due to the significant morbidity and mortality associated with the older
models of pulsatile ventricular assist devices, Canadian Cardiovascular Society
2003 guidelines and several European countries recommended that LVAD
patients cease driving both private and commercial vehicles. As a result, several
institutions advised patients to not drive after LVAD implantation. However, the
current generation of continuous-flow devices are substantially more reliable, and
thus in 2012, the Canadian Cardiovascular Society revised its recommendations to
indicate that stable patients supported with LVAD may drive a private (not
commercial) vehicle 2 months after implantation. This new recommendation was
based on a “Risk of Harm” formula.1,2 Currently, only some institutions follow these
guidelines, and as a result there is limited data on the driving patterns of patients
The VAD Journal: https://doi.org/10.13023/VAD.2017.05

Page 2 of 12

The VAD Journal: The journal of mechanical assisted circulation and heart failure

supported with continuous-flow LVADs. Hence, we decided to study driving
patterns and outcomes among patients supported with continuous-flow LVADs at
our institution using a standard questionnaire.
In order to understand the driving patterns of the patients before and after LVAD
implantation, we collected data on demographics, social and employment status,
clinical features and symptoms, driving habits, driving record, and personal
preferences that affected their decision to drive a private vehicle. In addition, we
obtained data regarding the driving instructions given by health care personnel at
the time of discharge. Lastly, we assessed the association between quality of life
and independent driving after LVAD implantation.

Methods
This study employed the use of an Institutional Review Board-approved study
design and questionnaire to address patient driving patterns before and after
LVAD implantation. The study population comprised all patients who received a
continuous-flow LVAD (HeartMate II [Thoratec Corp., Pleasanton, CA] or
HeartWare [HeartWare, Framingham, MA]) between January 2010 and January
2014 at our tertiary care center, who were alive at the time of the study. An
informed consent form and questionnaire were mailed to all the patients for
voluntary enrollment in research. Enrolled patients were encouraged to complete
the questionnaires and return the forms to our research personnel. We linked data
obtained from the questionnaire with an established clinical LVAD database and
analyzed factors associated with driving patterns after LVAD implantation. Data
are analyzed using descriptive statistics. Continuous variables are expressed as
mean±standard deviation (SD) or median±SD (when appropriate), and categorical
variables are expressed as frequency and percentage (%).

Results
There were 156 patients who underwent LVAD implantation between January
2010 and January 2014; 32 had died prior to our study and the remainder were
eligible for this protocol. The questionnaires were mailed to the homes of the 124
patients who were still alive and had received a continuous-flow LVAD. A total of
94 of 124 patients (75.8%) responded to the survey; the average age of the
respondents was 58 years, 69.2% were male, and 77.7% were supported for a
BTT indication. The majority of the patients were INTERMACS 3 or 4 (62.7%) at
the time of implantation, and 51% had ischemic cardiomyopathy. The average
ejection fraction was 16%, and the average body mass index was 28.7. Before
LVAD implantation, all 94 patients were living at home, 33% were employed, 98%
had a valid driver’s license, and 93% (87) were driving. Of those who drove, 56%
were driving daily for more than half an hour and 72% were driving more than 5
miles daily. Of the 87 patients who drove, 7 had had motor vehicle accidents
during the 12 months before LVAD implantation (Tables 1 and 2).
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Table 1. Baseline Demographics
Characteristics
Age

n=94
58.0±10.9

Male sex

65 (69.2)

Reason for LVAD
BTT

73 (77.7)

DT

17 (18.1)

DT to BTT

4 (4.3)

INTERMACS number
1

7 (7.4)

2

22 (23.4)

3

21 (22.3)

4

38 (40.4)

5

4 (4.2)

NA

2 (2.1)

Diagnosis
Idiopathic

38 (40.4)

Ischemic

51 (54.3)

Other

5 (5.3)

Ejection fraction

16.0±4.8

Body mass index

28.7±6.0

Hemoglobin

8.4±2.7

Creatinine

1.7±1.5

Living arrangement
Living at home

94 (100.0)

Living in urban area

62 (68.1)

Living alone

13 (17.1)

Employed

31 (33.3)

Pre-LVAD hospitalization

60 (65.2)

Data are presented as n (%) or mean±standard deviation.
BTT = bridge to transplant, DT = destination therapy.

The VAD Journal: https://doi.org/10.13023/VAD.2017.05

Page 4 of 12

The VAD Journal: The journal of mechanical assisted circulation and heart failure

Table 2 Baseline Driving Characteristics (n = 94)
Before LVAD Implantation
Characteristics

n (%)

Valid driver’s license

91 (97.9)

Driving

87 (92.6)

Afraid to drive

17 (18.3)

Driving distance (n = 87)
Less than 5 miles

24 (27.5)

5-20 miles

47 (54.0)

More than 20 miles

15 (17.2)

NA

1 (1.2)

Driving frequency (n = 87)
Daily

43 (49.4)

Less than 3 times/week

18 (20.6)

More than 3 times/week

25 (28.7)

NA

1 (1.2)

Drive duration (n = 87)
30 minutes

37 (43.8)

30-120 minutes

44 (49.4)

>2 hours
Automobile accident (n = 87)

6 (6.7)
7 (8.0)

ICD shock (n = 94)
Yes

33 (35.1)

No

50 (53.2)

No ICD

11 (11.7)

ICD = implantable cardioverter defibrillator,
LVAD = left ventricular assist device, NA = not available.
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After LVAD implantation, 86 patients were discharged to home and 8 patients were
discharged after a rehabilitation stay. Most often, patients initially had assistance
with their transportation needs from either a significant other (74%) or friends and
relatives (17%). A total of 41 patients had assistance with driving for up to 2
months. A total of 69 patients (77%) indicated that they remembered some sort of
instructions given by their health care providers regarding driving, and 95% of
them said they followed the instructions. After LVAD implantation, 12 patients
returned to gainful employment. Out of all patients in our cohort, 59 (69%)
admitted to driving (57 patients drove a car, 2 patients drove other vehicles) after
LVAD implantation, and 38 drove more than 5 miles daily, 26 drove more than 30
minutes daily, and 17 drove more than 100 miles at a time. Patients who drove
after LVAD implantation were younger (56 vs 62 years, p=0.02), had a shorter
length of hospital stay after LVAD implantation (13.7 vs 21.5 days, p=0.0134), and
were more likely to have been advised by their health care provider that they may
drive after LVAD implantation (p=0.004) (Table 3).
After discharge, 7 patients (11%) started driving within 2 weeks and 36 (56.2%)
drove within 2 to 8 weeks. Twenty-eight percent of the patients were afraid to start
driving; however, 75% of all patients were eventually confident in driving after
LVAD implantation. Twenty-six (30.2%) patients who were driving prior to LVAD
implantation stopped driving after their surgery, and 4 (4.3%) who were not driving
prior to LVAD started driving after the LVAD implantation (p<0.0001). Thirty-two
percent of the patients who were not afraid of driving before the LVAD developed a
fear of driving after LVAD implantation (p<0.01) (Table 3).
Ten patients had alarms while driving: 6 related to batteries, 2 related to suction
events, and 2 related to other reasons. All of these patients were able to safely pull
over to the side of the road and address these alarms without consequence. One
patient reportedly passed out while driving, resulting in a motor vehicle accident
without permanent injuries or fatalities. Prior to LVAD implantation, 83 (88.3%)
patients had an implantable cardioverter defibrillator (ICD), with 35.1% with a
history of previous ICD shock. During the LVAD support period, only 2 patients had
ICD shocks, and none occurred while driving.
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Table 3. Post-LVAD Driving Data
Characteristics (total n)

n

%

Driving instructions were provided

60

63.8

N/A
Physician advised that they can drive

3
69

3.2
73.4

4

4.3

61

88.4

5

5.3

Spouse

56

59.6

Others

20

21.3

N/A
Patients who were driving after LVAD

18
64

19.1
68.1

N/A
Post-LVAD Drivers Only (n=64)

1

1.1

Afraid to drive initially

20

31.0

N/A
Eventually confident to drive

5
48

7.8
75.0

8

12.5

≤2 weeks

7

10.9

2-8 weeks

36

56.3

>2 months

15

23.4

N/A
LVAD alarms while driving

6
16

9.4
25.0

N/A
Quality of life (n=94)

5

7.8

Happy that they were advised not to drive

11

11.7

1

1.1

Driving impacts quality of life

88

93.6

LVAD impacts driving ability

23

24.5

6

6.4

Discharge driving instructions (n = 94)

N/A
Driving advice followed (n = 69)
N/A
Post-LVAD (n = 94)
Had help with driving after LVAD

N/A
Time to resuming driving

N/A

N/A

LVAD = left ventricular assist device, N/A = not available; remaining %
represents the percentage of patients who responded “No” for the
respective questions.
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Among our cohort, 59 (62.7%) responded that they were
satisfied with their ability to drive. Eighty-two (87%) patients
replied that they would not be happy if they were advised not to
drive at all, and 11 (12%) patients were happy they were advised
not to drive. Eighty-eight (94%) patients responded that they
believe driving impacts quality of life, and 23 (26%) believed that
an LVAD affects driving ability (33% positively and 66%
negatively). Eighty-eight percent of patients said they think that
having an LVAD impacts the overall quality of life (of these, 76%
felt it was a positive impact and 24% negative) (Table 4, Figure
1).
Table 4. Differences in Characteristics of Patients Who Continued to Drive
and Who Stopped Driving After LVAD Implantation

Drivers Who
Stopped Driving
After LVAD

Drivers Who
Continued
Driving After
LVAD

(n = 26, 30.2%)

(n = 60, 69.8%)

Age (years)

62.4 ± 8.5

55.7 ± 11.5

0.0067

Length of hospital stay

21.5 ± 15.8

13.7 ± 6.6

0.0134

20 (76.9)

41 (68.3)

0.4204

BTT

19 (73.1)

48 (80.0)

0.6043

DT

5 (19.2)

10 (16.7)

DT to BTT

2 (7.7)

2 (3.3)

1 to 2

10 (40.0)

16 (27.1)

3 to 5

15 (60.0)

43 (72.9)

Pre-LVAD employed

13 (50.0)

17 (28.3)

0.0528

Pre-LVAD hospitalization

16 (61.5)

38 (64.4)

0.8002

Pre-LVAD afraid to drive

7 (26.9)

6 (10.2)

0.0480

Living in urban area

14 (58.3)

41 (69.5)

0.3297

Doctor approved driving post discharge

14 (60.9)

50 (84.8)

0.0189

Characteristics

Male sex

p

Reason for LVAD

INTERMACS number
0.2430

Data are presented as n (%) or mean ± standard deviation.
Bold represents statistical significance.
BTT = bridge to transplant, DT = destination therapy, LVAD = left ventricular assist
device.
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Figure 1. Trends of driving and fear of driving before and after LVAD implantation.
LVAD = left ventricular assist device.

Discussion
The current study shows that the majority of the patients (64 out of 94 [69%]) were
able to drive after LVAD implantation, and 17 (26%) patients were able to
continuously drive for more than 100 miles when needed. A few (n=10, 16%)
patients had alarms while driving, mostly related to battery changes. Only 1 (1.5%)
patient had syncope and a major motor vehicle accident; there were no fatalities.
In another similar, although multicenter, study of 201 patients with LVADs, 85% of
patients drove and 17% (29) had alarms, mostly related to battery changes (2
were because of device malfunction); there were 5 (2.9%) vehicle accidents, but
none were serious.3,4 Ambardekar et al. provided a survey to 83 ventricular assist
device coordinators regarding their practice’s policy for LVAD-supported patients
and driving and received responses from 33 of them.5 Of the respondents, 67%
reported that their programs allowed patients to return to driving after they
recovered from LVAD surgery, and 33% indicated that they did not allow LVAD
patients to drive. Eighty-seven percent of centers counseled their patients not to
drive if they had syncope.5
Driving recommendations are based on the estimation of risk of harm while driving
and the general consensus on the threshold of an acceptable risk of harm. The
annual risk of harm while driving can be estimated by this formula: driving time (%)
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× vehicle type (commercial or private) × annual risk of incapacitation × probability
of injury or accident.2 In general, it is an acceptable standard for a patient with
cardiovascular disease to drive if the risk of sudden cardiac incapacitation is less
than 22% per year for a private vehicle driver or less than 1% for a commercial
vehicle driver. Newer generation LVADs have demonstrated improved quality of
life and low risk for sudden cardiac incapacitation.6 Published contemporary trials
of continuous-flow LVAD devices and a large national data registry (INTERMACS)
demonstrate that 1-year mortality among LVAD patients is approximately 20%,
with one-third of deaths occurring in the first month. Most of the deaths during
follow-up are not sudden and reflect progressive deterioration and physical
debility. Estimates indicate an 8% to 12% rate of sudden cardiac incapacitation per
year after LVAD implantation in this population, which is substantially less than the
22% per year risk limit to drive a private vehicle.7 Hence, it was concluded that a
stable LVAD patient can drive a private vehicle 2 months after implantation.1
In our study, there were 2 ICD shocks after LVAD implantation. The American
Heart Association (AHA)/Heart Rhythm Society (HRS) guidelines recommend that
patients not drive for 6 months following an ICD discharge for ventricular
tachycardia or ventricular fibrillation, and the European Heart Rhythm Association
(EHRA) guidelines recommend they don’t drive for 3 months after such an event.
Also, for primary prevention ICD implantation, AHA/HRS guidelines recommend
patients should not drive for 1 week after implantation to allow for surgical recovery
and EHRA guidelines recommend a 4-week period before a return to driving.8-10
Appropriate shocks were reported in 24% of LVAD patients with ICDs for
ventricular arrhythmias at one center, but the rate of syncope was unknown.11
Ventricular fibrillation and ventricular tachycardia often result in syncope or nearsyncope among advanced heart failure patients not supported by LVAD, while
those supported with LVAD often maintain consciousness or are minimally
symptomatic despite these rhythm disturbances. Alarms related to suction events
caused by either positional inflow cannula obstruction or low volume state often do
not present with syncope. Suction events also are more common in the first month
after LVAD implantation and improve with pump speed adjustment during followup. Finally, cerebrovascular events occur in approximately 10% of LVADsupported patients and can cause motor function incapacitation. Two patients in
our study had suction events while driving and neither had any syncope or motor
vehicle accidents.
Some limitations of the study include recall bias, which is common to similarly
designed voluntary questionnaire studies. Furthermore, these responses only take
into account views from patients who are ambulatory and presumably stable from
a clinical perspective, and exclude those who have expired or may have suffered
various incapacitating complications that made them unable to respond to these
queries.
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Conclusions
Our data support the hypotheses that most patients who are ambulatory and
stable can safely return to driving after LVAD implantation without an increased
risk of motor vehicle accident and that the ability to drive substantially improves
quality of life in the LVAD-supported patient population. The present study
provides valuable information regarding driving patterns among a contemporary
patient population supported with continuous-flow LVADs. The data add to
established literature and may provide the basis for including lifestyle metrics to
larger registries (eg., INTERMACS). Furthermore, driving safety assessed by the
present protocol will extend and support current Canadian guidelines and
conceivably alter other national society guidelines (AHA, American College of
Cardiology, International Society for Health and Lung Transplantation). We believe
the information obtained from this study may help change clinical practice
recommendations and improve the quality of life for patients living with LVAD
support.
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